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Abstract
Conjugated linoleic acid (CLA) is a class of 28 positional and geometric isomers of linoleic acid octadecadienoic.
Currently, it has been described many benefits related to the supplementation of CLA in animals and humans, as
in the treatment of cancer, oxidative stress, in atherosclerosis, in bone formation and composition in obesity, in
diabetes and the immune system. However, our results show that, CLA appears to be not a good supplement in
patients with cachexia.
Conjugated linoleic acid (CLA) is a class of 28 positional
and geometric isomers of linoleic acid octadecadienoic
[1]. CLA is produced by ruminants, from linolenic
(18:3) and linoleic (18:2) unsaturated fatty acids
obtained in the diet. Therefore, the natural sources of
these substances are dairy products and red meat.
Despite of the variety of geometric isomers of linoleic
acid, they are present in nature mainly in (18:2) cis-9,
trans-11 and (18:2) trans-10, cis-12 forms [2].
Currently, it has been described many benefits related
to the supplementation of CLA in animals and humans,
as in the treatment of cancer, oxidative stress, in athero-
sclerosis, in bone formation and composition in obesity,
in diabetes and the immune system [3]. However, the
most studied effect in relation to CLA supplementation
is changes in lipid metabolism not only in animals but
also in humans [4].
Although several studies show a beneficial effect of
CLA supplementation on immune system parameters,
data showing a relationship between CLA and a possi-
ble improvement of the are still scarce. The few found
work related to CLA supplementation and decrease in
muscle proteolysis is directly related to the develop-
ment of cachexia. Yang and Cook [5] showed that
CLA supplementation reduced weight loss, and a
reduction of plasma TNF-a in cachetic rats induced by
injection of LPS (Lipopolysaccharide - inducing the
production of TNF-a by macrophages).
Graves et al. [6] showed that supplementation with
CLA in cachetic rats decreased the muscle mass losses,
due to a decrease of TNF-a receptors in the gastrocne-
mius muscle. A later study conducted by this group of
researchers found that after supplementation with CLA,
there was a decrease of the loss of muscle mass, without
changing the amount of TNF-a receptor 1 (TNFR1).
Thus it appears that this receptor is not actively contri-
buting to the increase of muscle proteolysis in cachexia
[6]. Studies by our group showed the effect of CLA sup-
plementation on parameters of lipid metabolism in
cachetic rats. Supplementation of CLA was not able to
reverse the lipid oxidation in the liver, decreased by
cachexia. Moreover, the CLA supplementation pro-
moted greater weight loss and greater accumulation of
fat in the liver (hepatic steatosis) and in the plasma [7].
Due to the lack of works explaining the mechanisms
which CLA supplementation inhibits muscle proteolysis
and the possible role of pro-inflammatory cytokines
(such as TNF-a), more researches are still necessary.
Despite these found results, CLA appears to be not a
good supplement in patients with cachexia.
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